Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Delivery
Pharma
Appeals court backs Regeneron's antitrust suit against Novartis
Novartis and Vetter must now defend against Regeneron's allegation that the companies conspired to delay a prefilled syringe version of Eylea.
Angus Liu
Mar 19, 2024 10:40am
Formosa snags FDA nod for reformulation of decades-old steroid
Mar 5, 2024 11:36am
Grifols preps blood clot treatment approval push after ph. 3 win
Feb 14, 2024 9:10am
BMS touts latest Opdivo data as I-O battle heads to new front
Jan 29, 2024 8:45am
Teva taps Royalty to bankroll long-acting schizophrenia drug
Nov 13, 2023 11:40am
Eisai, Biogen trot out data on injectable Leqembi
Oct 26, 2023 11:59am